(Q33818408)

29 July 2017

title

Mortality in people taking selegiline: observational study (English)

1 reference

29 July 2017

M Thorogood

1

1 reference

29 July 2017

B Armstrong

series ordinal

2

1 reference

29 July 2017

T Nichols

series ordinal

3

1 reference

29 July 2017

J Hollowell

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

29 July 2017

1 reference

29 July 2017

volume

317

1 reference

29 July 2017

issue

7153

1 reference

29 July 2017

page(s)

252-254

1 reference

The General Practice Research Database: quality of morbidity data

29 July 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28616

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

4 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28616

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

4 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28616

Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9677215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.317.7153.252

1 reference

29 July 2017

1 reference

29 July 2017

1 reference